US HB6915 | 2019-2020 | 116th Congress
Status
Spectrum: Slight Partisan Bill (Republican 2-1)
Status: Introduced on May 15 2020 - 25% progression, died in committee
Action: 2020-05-15 - Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Foreign Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on May 15 2020 - 25% progression, died in committee
Action: 2020-05-15 - Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Foreign Affairs Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Requires assessments of the response of the World Health Organization (WHO) to the COVID-19 (i.e., coronavirus disease 2019) pandemic. The Department of State shall report to Congress on the effectiveness, transparency, and accountability of the WHO's response to the COVID-19 pandemic, including an assessment of information about the pandemic that China conveyed to or withheld from the WHO. The report shall assess whether WHO regulations need to be updated and whether new mechanisms are needed to effectively address pandemics and increase accountability. Materials submitted in support of the President's annual budget shall include an assessment of (1) whether institutional reforms at the WHO are needed to ensure accountability and effectiveness, and (2) whether U.S. contributions to the WHO should be withheld in the absence of such reforms.
Title
Global COVID-19 Truth, Transparency, and Accountability Act
Sponsors
Rep. Christopher Smith [R-NJ] | Rep. Henry Cuellar [D-TX] | Rep. Mike Johnson [R-LA] |
History
Date | Chamber | Action |
---|---|---|
2020-05-15 | House | Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-05-15 | House | Referred to the Committee on Foreign Affairs, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
2020-05-15 | House | Introduced in House |
Subjects
Asia
Budget process
Cardiovascular and respiratory health
China
Congressional oversight
Emergency medical services and trauma care
Executive agency funding and structure
Foreign aid and international relief
Government ethics and transparency, public corruption
Health information and medical records
HIV/AIDS
Immunology and vaccination
Infectious and parasitic diseases
International affairs
International organizations and cooperation
Medical tests and diagnostic methods
Rule of law and government transparency
U.S. Agency for International Development (USAID)
United Nations
World health
Budget process
Cardiovascular and respiratory health
China
Congressional oversight
Emergency medical services and trauma care
Executive agency funding and structure
Foreign aid and international relief
Government ethics and transparency, public corruption
Health information and medical records
HIV/AIDS
Immunology and vaccination
Infectious and parasitic diseases
International affairs
International organizations and cooperation
Medical tests and diagnostic methods
Rule of law and government transparency
U.S. Agency for International Development (USAID)
United Nations
World health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/6915/all-info |
Text | https://www.congress.gov/116/bills/hr6915/BILLS-116hr6915ih.pdf |